Baudax Bio, Inc. Quarterly Debt-to-equity in % from Q3 2020 to Q3 2023

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Baudax Bio, Inc. quarterly Debt-to-equity history and growth rate from Q3 2020 to Q3 2023.
  • Baudax Bio, Inc. Debt-to-equity for the quarter ending September 30, 2023 was -178 %, a 104% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2023 -178 -5.23K -104% Sep 30, 2023
Q2 2023 -164 -3.22K -105% Jun 30, 2023
Q1 2023 -238 +10K +97.7% Mar 31, 2023
Q4 2022 -427 +1.69K +79.8% Dec 31, 2022
Q3 2022 5.05K +5.83K Sep 30, 2022
Q2 2022 3.06K +3.58K Jun 30, 2022
Q1 2022 -10.3K -9.95K -2986% Mar 31, 2022
Q4 2021 -2.12K -1.84K -656% Dec 31, 2021
Q3 2021 -779 -510 -190% Sep 30, 2021
Q2 2021 -525 Jun 30, 2021
Q1 2021 -333 Mar 31, 2021
Q4 2020 -280 Dec 31, 2020
Q3 2020 -269 Sep 30, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.